Rebaudioside M
High-intensity sweet compound from stevia leaf with cleaner taste and less bitterness than Reb A.
Should I eat Rebaudioside M?
Rebaudioside M is a highly refined, zero‑calorie stevia sweetener; whether made from leaf extraction, enzymatic conversion, or fermentation, the molecule is the same. Use it to cut sugar while keeping your total stevia intake within the ADI, and be extra mindful with young children since infant formula uses haven’t been evaluated in U.S. GRAS notices.
Summary
Rebaudioside M (Reb M) is one of stevia’s sweetest compounds. It can be isolated from the leaf or produced by enzyme conversion or microbial fermentation, and regulators judge the resulting Reb M to be chemically equivalent and safe. Safety limits are set at 0–4 mg/kg/day as steviol equivalents, so track how many stevia‑sweetened items you have in a day, especially for small children. Your gut converts it to steviol and you excrete it, so it doesn’t raise blood sugar; a 12‑week human trial found no meaningful change in gut microbiota. If you care about processing, know this is a highly purified ingredient rather than whole‑leaf, and labels may not specify the production route.
Key Research Points
Reb M can come from leaf extraction, enzyme conversion, or fermentation; regulators reviewed these routes and found the final Reb M chemically equivalent and safe. Health‑wise, the production method doesn’t change the risk profile; if you prefer leaf‑only sources, check brand info.
Overview
What is it?
Why is it used?
Origin
Stevia rebaudiana is native to Paraguay and Brazil, where Guaraní people used fresh leaves to sweeten yerba mate. Industrial extraction of steviol glycosides began in Japan in the 1970s. Rebaudioside M (a minor leaf glycoside) gained interest in the 2010s for its cleaner taste; because it occurs at low levels in leaf, producers either isolate it from large-scale extracts or make it by enzymatically converting other leaf glycosides or by fermentation using food-grade microbes.
Process: Extract, purify, optionally enzymatically convert
Steps
Chemicals
Research & Safety
Potential Concerns
As with any intense sweetener, it’s wise to keep intake within the ADI (0–4 mg/kg/day as steviol equivalents). EFSA’s 2024 assessment kept the ADI unchanged and noted that high‑end consumers, especially toddlers, could exceed it when products all use maximum permitted levels. In the U.S., most GRAS notices for Reb M exclude infant formula, so that specific use has not been evaluated in those submissions. Some Reb M on the market is made by fermentation with genetically modified yeast or by enzymatic conversion; EFSA found no safety concern and no residual DNA/viable cells in the finished additive, but shoppers who avoid such processes may wish to check labeling. ([efsa.onlinelibrary.wiley.com](https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2024.9045?utm_source=openai))
Potential Benefits
Reb M gives strong sweetness with virtually no calories and can help cut added sugars in drinks, yogurts, and tabletop sweeteners. Its potency is roughly 200–350× sucrose, so only tiny amounts are needed, often blended with bulk sweeteners for best texture. Many formulators prefer Reb M over older stevia glycosides (like Reb A) because it tastes cleaner with less bitterness. It is stable across beverage pH ranges and typical heat treatments. ([fda.gov](https://www.fda.gov/media/135361/download))
Digestive Effects
Most people tolerate Reb M well. Like other steviol glycosides, it reaches the colon largely intact, where gut microbes hydrolyze it to steviol; the body then converts steviol to steviol‑glucuronide and excretes it, with little exposure to the intact sweetener. A randomized trial over 12 weeks found no significant change in overall gut microbiota composition with stevia use at real‑world doses. Occasional mild bloating or aftertaste is reported by some individuals, but no laxative effect is expected (unlike some sugar alcohols). ([fda.gov](https://www.fda.gov/media/113131/download))
Limit Consumption
Young children who frequently consume many sweetened products could approach or exceed the ADI under worst‑case scenarios, so parents may want to moderate total exposure. For infants, most U.S. GRAS notices exclude formula uses, meaning added Reb M in infant formula is not covered by those notices. EFSA and earlier reviews found no reproductive or developmental toxicity concerns at doses underpinning the ADI, so typical adult use during pregnancy appears acceptable within the ADI. People who prefer to avoid ingredients made with genetically modified microbes can look for products labeled as leaf‑extract only; from a safety standpoint, EFSA reported no viable cells/DNA in fermentation‑derived Reb M and no safety concern. ([efsa.onlinelibrary.wiley.com](https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2024.9045?utm_source=openai))
Fact Sheet
Regulatory Status
ESG & Sustainability
Allergens and Diet
Natural Alternatives
Monk fruit
Allulose
Erythritol
Citations
GRN 1010 – Rebaudioside M obtained by enzymatic treatment
2022-01-26FDA CFSAN • FDA
GRN 882 – Rebaudioside M (fermentation)
2019-09-06FDA CFSAN • FDA
Safety evaluation of steviol glycoside preparations (enzymatic bioconversion)
2021-08-03EFSA FAF Panel • EFSA Journal
Safety of steviol glycosides predominantly Rebaudioside M produced by fermentation
2023-12-20EFSA FAF Panel • EFSA Journal
Steviol glycosides – evaluation and ADI
2016-01-01JECFA • WHO/FAO JECFA
Steviol glycosides (INS 960) – group details
2024-07-01FAO/WHO Codex • Codex GSFA
Reb D/M organoleptic properties
2025-05-15Shoji T. et al. • Journal of Agricultural and Food Chemistry
Stevia for 12 weeks does not alter human gut microbiota
2024-01-15Singh G., McBain A.J., McLaughlin J.T., Stamataki N.S. • Nutrients
GRN 744 – Steviol glycosides consisting primarily of Rebaudioside M
2017-12-01FDA CFSAN • FDA
GRN 733 – Purified steviol glycosides (conditions of use)
2017-11-03FDA CFSAN • FDA